Literature DB >> 32053306

ANCA-Associated Vasculitis - Refining Therapy with Plasma Exchange and Glucocorticoids.

Vimal K Derebail1, Ronald J Falk1.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32053306     DOI： 10.1056/NEJMe1917490

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic.

Authors:  Rabeea Siddique; Qian Bai; Muhammad Adnan Shereen; Ghulam Nabi; Guang Han; Farooq Rashid; Saeed Ahmed; Aigerim Benzhanova; Mengzhou Xue; Suliman Khan
Journal:  Hum Vaccin Immunother       Date:  2020-10-16       Impact factor: 3.452

2.  Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges.

Authors:  Dorian Nezam; Raphaël Porcher; François Grolleau; Pauline Morel; Dimitri Titeca-Beauport; Stanislas Faguer; Alexandre Karras; Justine Solignac; Noémie Jourde-Chiche; François Maurier; Hamza Sakhi; Khalil El Karoui; Rafik Mesbah; Pierre Louis Carron; Vincent Audard; Didier Ducloux; Romain Paule; Jean-François Augusto; Julien Aniort; Aurélien Tiple; Cédric Rafat; Séverine Beaudreuil; Xavier Puéchal; Pierre Gobert; Ziad Massy; Catherine Hanrotel; Stéphane Bally; Nihal Martis; Cécile-Audrey Durel; Geoffroy Desbuissons; Pascal Godmer; Aurélie Hummel; François Perrin; Antoine Néel; Claire De Moreuil; Tiphaine Goulenok; Dominique Guerrot; Steven Grange; Aurélie Foucher; Alban Deroux; Carole Cordonnier; Céline Guilbeau-Frugier; Anne Modesto-Segonds; Dominique Nochy; Laurent Daniel; Anissa Moktefi; Marion Rabant; Loïc Guillevin; Alexis Régent; Benjamin Terrier
Journal:  J Am Soc Nephrol       Date:  2022-01-24       Impact factor: 10.121

Review 3.  An outlook on potential protein targets of COVID-19 as a druggable site.

Authors:  Rubia Noori; Meryam Sardar
Journal:  Mol Biol Rep       Date:  2022-07-06       Impact factor: 2.742

Review 4.  COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses.

Authors:  Muhammad Adnan Shereen; Suliman Khan; Abeer Kazmi; Nadia Bashir; Rabeea Siddique
Journal:  J Adv Res       Date:  2020-03-16       Impact factor: 10.479

Review 5.  Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics).

Authors:  Saima Hamid; Mohammad Yaseen Mir; Gulab Khan Rohela
Journal:  New Microbes New Infect       Date:  2020-04-14

6.  Should PLEX Be Used for Severe AKI and/or Pulmonary Hemorrhage in ANCA-Associated Vasculitis (AAV)? PRO.

Authors:  Vimal K Derebail
Journal:  Kidney360       Date:  2021-05-27

Review 7.  Proposal for a more practical classification of antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Nestor Oliva-Damaso; Andrew S Bomback
Journal:  Clin Kidney J       Date:  2020-12-29

Review 8.  Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review.

Authors:  Karim Doughem; Ayman Battisha; Omar Sheikh; Lakshmi Konduru; Bader Madoukh; Mohammed Al-Sadawi; Shakil Shaikh
Journal:  Curr Cardiol Rev       Date:  2021

9.  Consideration of Therapeutic Plasma Exchange in Association With Inflammatory Lesions in ANCA-Associated Glomerulonephritis: A Real-World Retrospective Study From a Single Center.

Authors:  Désirée Tampe; Philipp Ströbel; Peter Korsten; Samy Hakroush; Björn Tampe
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

Review 10.  A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19).

Authors:  Maryam Rameshrad; Majid Ghafoori; Amir Hooshang Mohammadpour; Mohammad Javad Dehghan Nayeri; Hossein Hosseinzadeh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-05-19       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.